Comment: Safety and Efficacy of Apixaban Versus Warfarin in Patients With Advanced Chronic Kidney Disease

Please use this identifier to cite or link to this item: https://doi.org/10.1177/1060028018798755

DC Field	Value
dc.title	Comment: Safety and Efficacy of Apixaban Versus Warfarin in Patients With Advanced Chronic Kidney Disease
dc.contributor.author	Peh, Leticia Xyn Yen
dc.contributor.author	Narayanaswamy, Shyamala
dc.contributor.author	Wang, Aiwen
dc.date.accessioned	2022-06-14T08:04:33Z
dc.date.available	2022-06-14T08:04:33Z
dc.date.issued	2019-01-01
dc.identifier.citation	Peh, Leticia Xyn Yen, Narayanaswamy, Shyamala, Wang, Aiwen (2019-01-01). Comment: Safety and Efficacy of Apixaban Versus Warfarin in Patients With Advanced Chronic Kidney Disease. ANNALS OF PHARMACOTHERAPY 53 (1) : 101-102. ScholarBank@NUS Repository. https://doi.org/10.1177/1060028018798755
dc.identifier.issn	1060-0280
dc.identifier.issn	1542-6270
dc.identifier.uri	https://scholarbank.nus.edu.sg/handle/10635/227094
dc.language.iso	en
dc.publisher	SAGE PUBLICATIONS INC
dc.source	Elements
dc.subject	Science & Technology
dc.subject	Life Sciences & Biomedicine
dc.subject	Pharmacology & Pharmacy
dc.type	Letter
dc.date.updated	2022-06-10T07:34:54Z
dc.contributor.department	PHARMACY
dc.description.doi	10.1177/1060028018798755
dc.description.sourcetitle	ANNALS OF PHARMACOTHERAPY
dc.description.volume	53
dc.description.issue	1
dc.description.page	101-102
dc.published.state	Published
Appears in Collections:	Staff Publications Elements

File	Description	Size	Format	Access Settings	Version
Comment Safety and Efficacy of Apixaban Versus Warfarin in Patients With Advanced Chronic Kidney Disease (Ann Pharmacotherapy 2019).pdf	Published version	54.38 kB	Adobe PDF	CLOSED	Published

Check